Idera Pharmaceuticals Inc (IDRA)

[FatCat_Banker]

Help me out, please.

I've done my DD to the best of my ability. The only thing, aside from technical lingo - which I'll pick up on eventually, that remains ambiguous is whether IDRA will be pursuing/be pursued by big Pharma for a partner on psoriasis?

The conference call seemed ... confident as if resisting the idea. I take this as a bullish indicator that they feel that they can handle it and wish to enter the larger markets by themselves. But getting a partner can't hurt. It definitely won't hurt the PPS.

I'm excited about the entry into the cancer market. Hopefully they can be more forthcoming than NWBO was/is.

Thanks in advance.